Founded in 2019 by food scientist Laura Katz, Helaina is a biotechnology company on a mission to transform nutrition with human equivalent bioactive proteins. Developed with its precision fermentation platform, Helaina is selling effera™ to consumer brands and through strategic distribution partners; it will soon be available in consumer products, including from Kroma Wellness, The Feed, Levelle Nutrition and Healthgevity and via the distributor Mitsubishi International Food Ingredients, Inc.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 09/25/24 | $45,000,000 | Series B |
Avidity Partners Barrel Ventures CF Private Equity Heron Rock Fund Ingeborg Investments Primary Venture Partners Relish Works Siam Capital Spark Capital | undisclosed |
